Aminolevulinate Synthase 1-Directed Small Interfering RNAs

All categories
DBCAT005670Pharmacologic class

RNA interference therapies that inhibit aminolevulinate synthase-1 expression. A DrugBank category of 1 drug. 1 of them is approved.

Part of
Small Interfering RNA
Drugs

What you can answer from here — as of November 29, 2022

1DrugEach linked to its full drug card
Listed above
2Drug targetsEvery drug–target pair in the class, with bond type
Sign in
4Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Aminolevulinate Synthase 1-Directed Small Interfering RNAs share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In